Roda, Josephine R.
HRN: 21-45-16 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
06/07/2022
AMPICILLIN 1GM + SULBACTAM 500MG (VIAL)
06/07/2022
06/11/2022
IV
1.5gm
Q6
Abscess
Waiting Final Action
Indication: ProphylaxisEmpiric Type of Infection: Skin & Soft Tissue Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes